Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 2;14:177. doi: 10.1186/s12974-017-0953-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 9 — SUR1 is upregulated in demyelinating white matter and cortical lesions in MS patients. a, b Immunolabeling for SUR1 in control (CTR) white matter (WM) (a, left) and in demyelinating active (a, middle) and chronic active (a, right) WM lesions, shown at low (a) and high (b) magnification. c Immunolabeling for SUR1 in control (CTR) cortex (CTX) (c, left) and in demyelinating cortical lesion (c, right); asterisk, bottom of a sulcus; scale bars 250 μm (a, c) and 50 μm (b). d Semi-quantitative assessment of SUR1 immunolabeling in different types of demyelinating lesions; n = 4–6 lesions/type; note that CTR WM exhibited no specific labeling for SUR1; **P < 0.01, ***P < 0.001 with respect to respective controls (CTR)